Compare Illumina, Inc. (ILMN) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Stitch Fix Inc — how do they compare? Illumina, Inc. trades at $182.09 (market cap $27.94B), while Stitch Fix Inc trades at $3.94 (market cap $520.36M). The key difference: Illumina, Inc. is far larger — about 53.7× Stitch Fix Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | SFIX | |
|---|---|---|
Market Cap | $27.94B | $520.36M |
Sector | Health | Consumer Cyclical |
52-Week High | $194.33 | $5.83 |
52-Week Low | $91.00 | $3.06 |
Enterprise Value | $29.33B | $408.08M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Stitch Fix (SFIX) trades at $3.935, up 3.83% on the day, showing signs of a potential turnaround with recent earnings beats and a bullish technical signal. The company reported a narrowed net loss in 2025, with revenue stabilizing at $1.27 billion and a gross margin of 43.66%. Analyst consensus is a $4.75 price target, though the stock remains near historic lows, presenting a value opportunity amid improving client metrics and AI-driven personalization efforts.
The outlook for SFIX hinges on sustained execution of its turnaround strategy, with risks including consumer spending pressure and competitive threats. Upside potential exists if margin improvements and active client growth continue, but investors should weigh the company's history of net losses against recent positive momentum and analyst caution, with 63.64% holding a neutral stance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
